Itrocainide
- Level
- Commodity
- Parent
- 51122800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51122803This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 79EDP2VHY8. European Medicines Agency schedules Itrocainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08355MIG. Itrocainide generally arises in the molecular formula C23H27N3O. The term ITROCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, list 25.) ITROCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule itrocainide under HS 29334990 and SITC 51575. As of Q4 2014, ITROCAINIDE remains US FDA's Preferred Term for this commodity. Itrocainide bears US NLM identifiers UMLS ID C1881286 and NCI Concept Code C65993. SMILES: O=C(NCCN(CC)CC)C1C2C(C(NC1)C1C(CCCC1)C)CCCC2.
Same parent
Under 51122800 · 7Activities that produce or sell this
KBLI · 8Inherited from family 51120000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.